Managing Small Airways Dysfunction in COPD Patients in Real Life Under Fixed Triple Combination of Beclomethasone/Formoterol/Glycopyrronium: The MASCOT Real World Evidence Study
Extrafine triple therapy improved SAD and spirometric parameters, leading to improvement in health status at 4 weeks. These results need to be confirmed in longer studies.
Authors
- Κonstantinos Κatsoulis (ORCID: https://orcid.org/0000-0003-2432-183X)
- Stavros Τryfon (ORCID: https://orcid.org/0000-0001-5102-0480)
- Dimitrios Potonos (ORCID: https://orcid.org/0009-0006-6175-8036)
- Maria Kipourou (ORCID: https://orcid.org/0000-0002-2358-2117)
- Evangelia Fouka (ORCID: https://orcid.org/0000-0003-4456-8987)
- Athena Gogali (ORCID: https://orcid.org/0000-0002-4321-9446)
- Κonstantinos Porpodis (ORCID: https://orcid.org/0000-0001-7215-2191)
- Christos Kyriakopoulos (ORCID: https://orcid.org/0000-0001-8806-2561)
- Efthymia Papadopoulou (ORCID: https://orcid.org/0000-0002-2415-0842)
- Ioanna Tsiouprou (ORCID: https://orcid.org/0000-0001-8740-3504)
- Κonstantinos Κostikas (ORCID: https://orcid.org/0000-0003-0774-3942)
Institutions
- University of Ioannina (GR)
- 424 General Military Hospital (GR)
- G. Papanikolaou General Hospital (GR)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/copd.s513350
- Citations
- 2
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04